BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10615239)

  • 1. The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas.
    Sarela AI; Farmery SM; Markham AF; Guillou PJ
    Eur J Cancer; 1999 Aug; 35(8):1264-7. PubMed ID: 10615239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions.
    Sanchez-Cespedes M; Okami K; Cairns P; Sidransky D
    Genes Chromosomes Cancer; 2000 Mar; 27(3):319-22. PubMed ID: 10679922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma.
    Krishnamurthy J; Kannan K; Feng J; Mohanprasad BK; Tsuchida N; Shanmugam G
    Oral Oncol; 2001 Apr; 37(3):222-4. PubMed ID: 11287275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
    Gunduz M; Ouchida M; Fukushima K; Hanafusa H; Etani T; Nishioka S; Nishizaki K; Shimizu K
    Cancer Res; 2000 Jun; 60(12):3143-6. PubMed ID: 10866301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer.
    Chen LS; Wei JB; Zhou YC; Zhang S; Liang JL; Cao YF; Tang ZJ; Zhang XL; Gao F
    World J Gastroenterol; 2005 Oct; 11(39):6120-4. PubMed ID: 16273637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction.
    Hara Y; Zheng Z; Evans SC; Malatjalian D; Riddell DC; Guernsey DL; Wang LD; Riabowol K; Casson AG
    Cancer Lett; 2003 Mar; 192(1):109-16. PubMed ID: 12637159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
    Luo ZG; Tang H; Li B; Zhu Z; Ni CR; Zhu MH
    Oncol Rep; 2011 Apr; 25(4):1073-81. PubMed ID: 21286670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia.
    Ito K; Kinjo K; Nakazato T; Ikeda Y; Kizaki M
    Am J Hematol; 2002 Feb; 69(2):141-3. PubMed ID: 11835353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of ING1 expression in sporadic breast cancer.
    Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K
    Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines.
    Campos EI; Cheung KJ; Murray A; Li S; Li G
    Br J Dermatol; 2002 Apr; 146(4):574-80. PubMed ID: 11966686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
    Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair.
    Campos EI; Martinka M; Mitchell DL; Dai DL; Li G
    Int J Oncol; 2004 Jul; 25(1):73-80. PubMed ID: 15201991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M; Ozaki T; Todo S; Nakagawara A
    Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer.
    Oki E; Maehara Y; Tokunaga E; Kakeji Y; Sugimachi K
    Cancer Lett; 1999 Dec; 147(1-2):157-62. PubMed ID: 10660101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer.
    Chen L; Matsubara N; Yoshino T; Nagasaka T; Hoshizima N; Shirakawa Y; Naomoto Y; Isozaki H; Riabowol K; Tanaka N
    Cancer Res; 2001 Jun; 61(11):4345-9. PubMed ID: 11389058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34.
    Zeremski M; Horrigan SK; Grigorian IA; Westbrook CA; Gudkov AV
    Somat Cell Mol Genet; 1997 May; 23(3):233-6. PubMed ID: 9330636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences.
    Scott M; Boisvert FM; Vieyra D; Johnston RN; Bazett-Jones DP; Riabowol K
    Nucleic Acids Res; 2001 May; 29(10):2052-8. PubMed ID: 11353074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.
    Tallen G; Kaiser I; Krabbe S; Lass U; Hartmann C; Henze G; Riabowol K; von Deimling A
    Int J Cancer; 2004 Apr; 109(3):476-9. PubMed ID: 14961591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.